We are live on ! Find out more
CFA

Carroll Financial Associates Portfolio holdings

AUM $1.88B
1-Year Est. Return 20.52%
This Fund
S&P 500
This Quarter Est. Return
+6.1%
1 Year Est. Return
+20.52%
3 Year Est. Return
+80.57%
5 Year Est. Return
+102.34%
10 Year Est. Return
AUM
$1.77B
AUM Growth
+$141M
Cap. Flow
+$46.8M
Cap. Flow %
2.65%
Top 10 Hldgs %
44.14%
Holding
1,921
New
180
Increased
518
Reduced
408
Closed
128

Sector Composition

Rank Sector Weight
1 Technology 7.04%
2 Financials 5.72%
3 Healthcare 2.51%
4 Consumer Discretionary 2.21%
5 Consumer Staples 1.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SUM
1451
DELISTED
Summit Materials, Inc. Class A Common Stock
SUM
$5K ﹤0.01%
151
NS
1452
DELISTED
NuStar Energy L.P.
NS
$5K ﹤0.01%
300
PRSRU
1453
DELISTED
Prospector Capital Corp. Unit
PRSRU
$5K ﹤0.01%
+535
New +$5.38K
HNGR
1454
DELISTED
Hanger Inc.
HNGR
$5K ﹤0.01%
200
SPXZ
1455
DELISTED
Morgan Creek Exos SPAC Originated ETF
SPXZ
$5K ﹤0.01%
+276
New +$5.55K
SOLN
1456
DELISTED
The Southern Company
SOLN
$5K ﹤0.01%
115
DISCK
1457
DELISTED
Discovery, Inc. Series C Common Stock
DISCK
$5K ﹤0.01%
174
+18
+12% +$559
GMIIU
1458
DELISTED
Gores Metropoulos II, Inc. Unit
GMIIU
$5K ﹤0.01%
+544
New +$5.54K
MBT
1459
DELISTED
Mobile TeleSystems Public Joint Stock Company American Depositary Shares (Each representing 2 Shares
MBT
$5K ﹤0.01%
577
-141
-20% -$1.25K
ACM icon
1460
Aecom
ACM
$9.75B
$4K ﹤0.01%
65
ARCT icon
1461
Arcturus Therapeutics
ARCT
$211M
$4K ﹤0.01%
131
BB icon
1462
BlackBerry
BB
$5.26B
$4K ﹤0.01%
400
BCRX icon
1463
BioCryst Pharmaceuticals
BCRX
$2.4B
$4K ﹤0.01%
294
BGY icon
1464
BlackRock Enhanced International Dividend Trust
BGY
$529M
$4K ﹤0.01%
622
BIO icon
1465
Bio-Rad Laboratories Class A
BIO
$9.42B
$4K ﹤0.01%
7
BSVN icon
1466
Bank7 Corp
BSVN
$481M
$4K ﹤0.01%
233
BWXT icon
1467
BWX Technologies
BWXT
$15.6B
$4K ﹤0.01%
82
-34
-29% -$2.19K
CE icon
1468
Celanese
CE
$4.82B
$4K ﹤0.01%
30
-19
-39% -$3.02K
CIK
1469
Credit Suisse Asset Management Income Fund
CIK
$134M
$4K ﹤0.01%
1,373
CLOV icon
1470
Clover Health Investments
CLOV
$2.51B
$4K ﹤0.01%
+327
New +$3.21K
DBC icon
1471
Invesco DB Commodity Index Tracking Fund
DBC
$1.66B
$4K ﹤0.01%
219
DBEU icon
1472
Xtrackers MSCI Europe Hedged Equity ETF
DBEU
$799M
$4K ﹤0.01%
127
DORM icon
1473
Dorman Products
DORM
$4.18B
$4K ﹤0.01%
42
FEX icon
1474
First Trust Large Cap Core AlphaDEX Fund
FEX
$1.61B
$4K ﹤0.01%
56
GH icon
1475
Guardant Health
GH
$22.6B
$4K ﹤0.01%
36

Similar funds

Carroll Financial Associates's Q2 2021 Portfolio in Review

As of Q2 2021, Carroll Financial Associates held 1,921 positions worth $1.77B, up 8.7% from $1.63B the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Carroll Financial Associates's Q2 2021 filing shows 180 new, 518 increased, 408 reduced and 128 closed positions. Its largest new stake was 26 Capital Acquisition Corp: 423,058 shares worth $4.11M. The largest sale was iShares MSCI USA Min Vol Factor ETF, an estimated $8.35M.

By sector, the portfolio is most concentrated in Technology at 7% of assets, up from 6.9% a quarter earlier, followed by Financials and Healthcare.

  • Carroll Financial Associates's largest Q2 2021 buy was 26 Capital Acquisition Corp: 423,058 shares worth $4.11M.
  • Carroll Financial Associates added most to Armor US Equity Index ETF in Q2 2021, an estimated $18.5M increase.
  • Carroll Financial Associates's biggest Q2 2021 reduction was iShares MSCI USA Min Vol Factor ETF, cutting an estimated $8.35M.
  • Carroll Financial Associates fully exited iShares US Oil Equipment & Services ETF in Q2 2021, selling an estimated $618K.
  • Carroll Financial Associates's ten largest holdings make up 44% of its $1.77B portfolio in Q2 2021.
  • Carroll Financial Associates opened 180 new positions and closed 128 in Q2 2021.
  • Carroll Financial Associates's portfolio value rose 8.7% quarter-over-quarter to $1.77B.

Based on Carroll Financial Associates's 13F filing for Q2 2021, filed 13 Jul 2021.